Celltrion
068270.KS
#706
Rank
โ‚น3.299 T
Marketcap
โ‚น15,083
Share price
-1.45%
Change (1 day)
41.03%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น172.38. In 2024 the company made an earnings per share (EPS) of โ‚น122.16 a decrease over its 2023 EPS that were of โ‚น242.24.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น165.1035.16%
2024โ‚น122.16-49.57%
2023โ‚น242.24-2.08%
2022โ‚น247.38-11.72%
2021โ‚น280.222.03%
2020โ‚น274.6382.8%
2019โ‚น150.2318.31%
2018โ‚น126.98-36.33%
2017โ‚น199.45161.25%
2016โ‚น76.352.86%
2015โ‚น74.2217.84%
2014โ‚น62.995.87%
2013โ‚น59.49-70.85%
2012โ‚น204.09134.09%
2011โ‚น87.1943.59%
2010โ‚น60.7274.49%
2009โ‚น34.80317.8%
2008โ‚น8.33-71.7%
2007โ‚น29.43